Search research articles
Contact Us
Filters
Showing results (91-100 of 599) with videos related to
Page
of 60
Sort By:
Cardiovascular Research
|
December 5, 2019
Matrix metalloproteinase-2 activation: critical to myocardial contractile dysfunction following ischaemia-reperfusion
John D Horowitz, Cher-Rin Chong
Pharmacology & Therapeutics
|
January 1, 1987
Photoaffinity labeling of thyroid hormone receptors
Z D Horowitz, H H Samuels
Trends in Cardiovascular Medicine
|
January 27, 2024
Editorial commentary: Oral anticoagulation for hemodialysis patients with atrial fibrillation: The therapeutic conundrum remains
John D Horowitz, Natasha M Rogers
Heart (British Cardiac Society)
|
March 31, 2005
Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk
A K Nightingale, J D Horowitz
Australian and New Zealand Journal of Medicine
|
June 1, 1984
Perhexilene neuropathy: a report of two cases
A J Goble, J D Horowitz
American Journal of Physiology. Heart and Circulatory Physiology
|
March 10, 2023
Understanding Takotsubo syndrome: first evaluate your mouse model
John D Horowitz, Sven Y Surikow
The Annals of Thoracic Surgery
|
December 1, 1987
Impalement injuries
M D Horowitz, J L Ochsner
The Medical Journal of Australia
|
March 24, 1979
Long-term safety of perhexiline maleate
J D Horowitz, M L Mashford
Clinical and Experimental Pharmacology & Physiology
|
July 23, 1998
Elimination, but not accumulation, of metoprolol by rat isolated perfused heart is selectively impaired by hypoxia
R H Ritchie, J D Horowitz
The Medical Journal of Australia
|
June 2, 1979
Perhexiline maleate in the treatment of severe angina pectoris
J D Horowitz, M L Mashford
Page
of 60
Search research articles
Search
Showing results (91-100 of 599) with videos related to
Sort By:
Page
of 60
Cardiovascular Research
|
December 5, 2019
Matrix metalloproteinase-2 activation: critical to myocardial contractile dysfunction following ischaemia-reperfusion
John D Horowitz, Cher-Rin Chong
Pharmacology & Therapeutics
|
January 1, 1987
Photoaffinity labeling of thyroid hormone receptors
Z D Horowitz, H H Samuels
Trends in Cardiovascular Medicine
|
January 27, 2024
Editorial commentary: Oral anticoagulation for hemodialysis patients with atrial fibrillation: The therapeutic conundrum remains
John D Horowitz, Natasha M Rogers
Heart (British Cardiac Society)
|
March 31, 2005
Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk
A K Nightingale, J D Horowitz
Australian and New Zealand Journal of Medicine
|
June 1, 1984
Perhexilene neuropathy: a report of two cases
A J Goble, J D Horowitz
American Journal of Physiology. Heart and Circulatory Physiology
|
March 10, 2023
Understanding Takotsubo syndrome: first evaluate your mouse model
John D Horowitz, Sven Y Surikow
The Annals of Thoracic Surgery
|
December 1, 1987
Impalement injuries
M D Horowitz, J L Ochsner
The Medical Journal of Australia
|
March 24, 1979
Long-term safety of perhexiline maleate
J D Horowitz, M L Mashford
Clinical and Experimental Pharmacology & Physiology
|
July 23, 1998
Elimination, but not accumulation, of metoprolol by rat isolated perfused heart is selectively impaired by hypoxia
R H Ritchie, J D Horowitz
The Medical Journal of Australia
|
June 2, 1979
Perhexiline maleate in the treatment of severe angina pectoris
J D Horowitz, M L Mashford
Page
of 60